본문 바로가기
KERD
논문KCI 등재

전립선증식증(Benign Prostatic Hyperplasia)의 한의 임상 진료 현황 조사를 위한 온라인 설문 조사

Clinical Practice Patterns for Benign Prostatic Hyperplasia: An Online Survey

조충식|신선미|백지수
대한한방내과학회 (The Society Of Korean Oriental Internal Medicine)|2023.09|대한한방내과학회지 (The Journal of Korean Oriental Internal Medicine)|제44권 제4호|pp. 703-725

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

surveybenign prostatic hyperplasiaclinical practice guidelineclinical practice pattern
주제분류한의학

초록

Objectives: This study investigated Korean medicine doctors’ perspectives on clinical practice patterns in the process of developing Korean medicine clinical practice guidelines for benign prostatic hyperplasia. Methods: A questionnaire was developed for Korean medicine doctors. A total of 323 oriental medicine doctors participated in the survey, which was live for a total of 9 days from September 22, 2022, to September 30, 2022. Results: Regarding awareness of treatments for benign prostatic hyperplasia, 63.8% of respondents showed high awareness of Korean medical treatments. However, items such as diagnostic criteria (17.7%), evaluation methods (17.0%), and Western medical treatments (22.9%) showed low recognition rates. In clinical practice, 76.2% of respondents were found to treat five or fewer patients with benign prostatic hyperplasia per month, and the average treatment period was 1 to 3 months for most at 41.2%. Korean medicine doctors diagnosed benign prostatic hyperplasia based on clinical features. The main interventions used were acupuncture, herbal medicine (prescription medicine), and moxibustion. This study has several limitations because of the low response rate for this survey; therefore, the participants are not representative of all Korean medicine doctors. In addition, because the study was conducted broadly on various topics related to benign prostatic hyperplasia, sufficient quality management was not carried out. Further studies that include a larger sample size and more in-depth studies on benign prostatic hyperplasia are needed. Conclusions: It is necessary to develop appropriate and reasonable Korean medicine clinical practice guidelines for benign prostatic hyperplasia.

Abstract

Objectives: This study investigated Korean medicine doctors’ perspectives on clinical practice patterns in the process of developing Korean medicine clinical practice guidelines for benign prostatic hyperplasia. Methods: A questionnaire was developed for Korean medicine doctors. A total of 323 oriental medicine doctors participated in the survey, which was live for a total of 9 days from September 22, 2022, to September 30, 2022. Results: Regarding awareness of treatments for benign prostatic hyperplasia, 63.8% of respondents showed high awareness of Korean medical treatments. However, items such as diagnostic criteria (17.7%), evaluation methods (17.0%), and Western medical treatments (22.9%) showed low recognition rates. In clinical practice, 76.2% of respondents were found to treat five or fewer patients with benign prostatic hyperplasia per month, and the average treatment period was 1 to 3 months for most at 41.2%. Korean medicine doctors diagnosed benign prostatic hyperplasia based on clinical features. The main interventions used were acupuncture, herbal medicine (prescription medicine), and moxibustion. This study has several limitations because of the low response rate for this survey; therefore, the participants are not representative of all Korean medicine doctors. In addition, because the study was conducted broadly on various topics related to benign prostatic hyperplasia, sufficient quality management was not carried out. Further studies that include a larger sample size and more in-depth studies on benign prostatic hyperplasia are needed. Conclusions: It is necessary to develop appropriate and reasonable Korean medicine clinical practice guidelines for benign prostatic hyperplasia.

참고문헌 (20)

  1. Kidney Internal medicine Committee of Korean Medicine, "Kidney Internal Medicine", pp.164~167 (2015), Gunjachulpansa
  2. The Korean Urological Associaton, "Urology", pp.245~253 (2019), Iljogak
  3. The Korean Prostate Society, "Textbook of Benign Prostatic Hyperplasia", pp.133~145 (2015), Iljogak
  4. Chughtai B, "Benign Prostatic Hyperplasia", Nature Reviews Disease Primers, 2(1), pp.16031~ (2016)
  5. Devlin CM, "Benign Prostatic Hyperplasia-What Do We Know?", BJU International, 127(4), pp.389~399 (2021)
  6. Eum HS, "Clinical Report on a Patient with Benign Prostatic Hyperplasia diagnosed as the Deficiency of Yang of the Kidney", The Journal of the Korea institute of oriental medical informatics, 10(2), pp.8~16 (2004)
  7. "Statistics of Disease/Behavior"[URL]
  8. "Statistics of Disease/Behavior"[URL]
  9. The Korean Urological Association, "Korean Clinical Practice Guideline for benign prostatic Hyperplasia", pp.23~144 (2015), Aplus
  10. Lerner LB, "Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia : AUA Guideline Part I—Initial Work-up and Medical Management", Journal of Urology, 206(4), pp.806~817 (2021)
  11. Lerner LB, "Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia : AUA Guideline Part II—Surgical Evaluation and Treatment", Journal of Urology, 206(4), pp.818~826 (2021)
  12. 김현영, "Mouse의 신장상피세포에서 敗醬추출물이 산화 스트레스 및 NF-κB signaling에 미치는 영향", 대한한방내과학회지, 31(1), pp.153~165 (2010), 대한한방내과학회
  13. Gang HM, "Two Cases of Benign Prostatic Hyperplasia with Bee Venom Pharmacopunture Therapy", Journal of Korean Institute of Pharmacopuncture, 11(2), pp.125~130 (2008)
  14. 박성환, "전침 및 봉약침치료를 시술한 양성전립선비대증 환자의 임상증상개선에 대한 후향적 단면연구", 대한한방내과학회지, 31(3), pp.437~447 (2010), 대한한방내과학회
  15. Ma CH, "Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia : systematic review of randomized controlled trials", Asian J Androl, 15(4), pp.471~482 (2013)
  16. Wang S, "Meta-analysis of efficacy and safety of Qianliexin capsule combined with western medicine in the treatment of benign prostatic hyperplasia", TMR Integr Med, 5, pp.e21020~ (2021)
  17. Zhang W, "Acupuncture for benign prostatic hyperplasia : A systematic review and meta-analysis", PLOS ONE, 12(4), pp.e0174586~ (2017)
  18. 배고은, "전립선 비대증에 대한 뜸치료의 효과 : 체계적 문헌고찰과 메타분석", 대한한방내과학회지, 39(3), pp.372~388 (2018), 대한한방내과학회
  19. Chen Z, "Acupuncture and moxibustion treating lower urinary tract symptoms due to benign prostatic hyperplasia : a systematic review and network meta-analysis", Acupuncture and Herbal Medicine, 2(2), pp.84~90 (2022)
  20. 이승훈, "요통에 관한 침구임상 진료지침 프로토콜 개발을 위한 전자우편 설문조사", Journal of Acupuncture Research, 26(3), pp.115~131 (2009), 대한침구의학회

관련 논문AI추천

전립선비대증 변증도구 개발 기초 연구박양춘, 이지윤, 정인철, 정호영, 조충식대한한방내과학회 · 대한한방내과학회지2017 · 제38권 제3호전립선비대증 변증도구의 신뢰도 평가 및 IPSS, 요속과의 상관관계에 대한 탐색적 연구강위창, 구지향, 이은정, 장은수, 전천후, 정인철, 조충식대한한방내과학회 · 대한한방내과학회지2020 · 제41권 제6호전립선비대증에 대한 치료의 근거 : 임상논문을 중심으로김대건, 김소연, 박성하, 윤한성, 이지혜, 조한신, 최준용, 한창우한의병리학회 · 동의생리병리학회지2015 · 제29권 제5호만성 전립선염에 대한 국내 한의학 임상 논문 경향 분석박상민, 백지훈, 신재욱, 이은지, 이지윤, 조온유, 최새롬대한한방내과학회 · 대한한방내과학회지2023 · 제44권 제6호전립선 비대증에 대한 뜸치료의 효과 : 체계적 문헌고찰과 메타분석이인, 권정남, 김소연, 박성하, 배고은, 윤영주, 이승환, 최준용, 한창우, 홍진우대한한방내과학회 · 대한한방내과학회지2018 · 제39권 제3호전침 및 봉약침치료를 시술한 양성전립선비대증 환자의 임상증상개선에 대한 후향적 단면연구강지석, 박성환, 안세영, 안영민, 이병철, 이혜정, 한수련대한한방내과학회 · 대한한방내과학회지2010 · 제31권 제3호

이 간행물의 다른 논문 (15건)

파킨슨병에 동반된 수면장애의 한약 치료에 대한 임상 연구 동향: 무작위 대조연구를 중심으로백경민, 강지현pp. 603-620만성 췌장염의 한약 치료에 대한 최근 중의 임상 연구 동향 고찰고석재, 박채현, 박재우, 김민정pp. 621-634기능성 소화불량 환자의 간 기능에 대한 한약 투여의 안전성: 단일 센터 후향적 연구정해인, 최수현, 김진성, 금창열, 한아람, 윤채림, 정나현, 하나연, 정다희pp. 635-644기능성소화불량 환자의 BMI에 따른 변증 유형 분포 및 다빈도 처방 분석 : 후향적 차트 리뷰하나연, 한아람, 김진성, 최수현, 정나현, 정다희, 정해인, 금창열, 윤채림pp. 645-660표준 치료를 받고 있는 제2형 당뇨병 환자에서 혈당강하제와 평위산 및 향사평위산 병용 투여가 혈당에 미치는 영향 및 안정성 연구정우녕, 노지원, 안세영, 안영민, 오승현, 송미령, 이병철pp. 661-674
원문 보기